Acadia Pharmaceuticals buy UBS Group AG
Start price
06.01.26
/
50%
€23.07
Target price
06.01.27
€34.12
Performance (%)
-1.13%
Price
12.01.26
€22.81
Summary
This prediction is currently active. With a performance of -1.13%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | -1.13% |
| iShares Core DAX® | 2.331% |
| iShares Nasdaq 100 | 2.077% |
| iShares Nikkei 225® | 2.759% |
| iShares S&P 500 | 1.613% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $40.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.27
04.12.25
04.12.25
-
04.12.26
04.12.26
-1.98%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
8.83%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
7.85%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24